![](/img/cover-not-exists.png)
Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709)
Kulik, Alexander, Abreu, Amy M., Boronat, Viviana, Ruel, MarcVolume:
59
Language:
english
Journal:
Contemporary Clinical Trials
DOI:
10.1016/j.cct.2017.06.006
Date:
August, 2017
File:
PDF, 264 KB
english, 2017